Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health
- PMID: 31536650
- DOI: 10.1002/cncr.32512
Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health
Abstract
Background: Survivors of childhood leukemia/lymphoma are at increased risk for reduced bone mineral density (BMD). The authors sought to determine the frequency of reduced BMD detected by off-therapy surveillance, factors associated with reduced BMD, and the association of reduced BMD with fractures.
Methods: This cross-sectional study included childhood leukemia/lymphoma survivors attending 2 survivorship clinics who received guideline-recommended BMD surveillance ≥2 years post-therapy with dual-energy x-ray absorptiometry (from January 1, 2004 to August 31, 2016). Lumbar spine BMD z-scores were height-for-age-adjusted. Low and very low BMD were >1 SD and >2 SDs below norms, respectively. Treatment, chronic conditions, and fractures were abstracted from medical records. Logistic regression was used to examine the association of low BMD with patient/treatment factors and fractures.
Results: In total, 542 patients (51.5% female) with a mean age of 15.5 years (range, 4.4-52.2 years) who were 6 years post-therapy (range, 2.0-35.1 years) were evaluated, including 116 who reported post-therapy fractures. Lumbar spine low BMD was identified in 17.2% of survivors, and very low BMD was identified in 3.5% of survivors, but frequencies varied considerably between subgroups; 10.8% of survivors aged 15 to 19 years at diagnosis had very low BMD. In multivariable analyses, older age at diagnosis, white race, and being underweight were significantly associated with low BMD. Survivors with low BMD had greater odds of nondigit fractures (odds ratio, 2.2; 95% CI, 1.3-3.7) and specifically long-bone fractures (odds ratio, 2.7; 95% CI, 1.5-4.7).
Conclusions: In this study of childhood leukemia/lymphoma survivors undergoing guideline-recommended dual-energy x-ray absorptiometry surveillance, patients who were older at diagnosis, white, and underweight were at the highest risk for lumbar spine low BMD. Low BMD was associated with a greater risk of fractures, emphasizing the clinical importance of surveillance.
Keywords: bone mineral density; cancer survivors; childhood cancer; dual-energy x-ray absorptiometry (DXA) scan; fractures; leukemia; lymphoma.
© 2019 American Cancer Society.
Similar articles
-
Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.Lancet Diabetes Endocrinol. 2023 Jan;11(1):21-32. doi: 10.1016/S2213-8587(22)00286-8. Epub 2022 Dec 10. Lancet Diabetes Endocrinol. 2023. PMID: 36513116
-
No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26271. Epub 2016 Sep 26. Pediatr Blood Cancer. 2017. PMID: 27671543
-
Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.J Bone Miner Res. 2024 Mar 22;39(2):130-138. doi: 10.1093/jbmr/zjad013. J Bone Miner Res. 2024. PMID: 38477791
-
Bone Mineral Density in Survivors of Childhood Cancer: A Meta-Analysis.Pediatrics. 2024 Aug 1;154(2):e2024066081. doi: 10.1542/peds.2024-066081. Pediatrics. 2024. PMID: 39076127
-
Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Lancet Diabetes Endocrinol. 2021 Sep;9(9):622-637. doi: 10.1016/S2213-8587(21)00173-X. Epub 2021 Jul 30. Lancet Diabetes Endocrinol. 2021. PMID: 34339631 Free PMC article. Review.
Cited by
-
A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study.Arch Osteoporos. 2021 Feb 26;16(1):45. doi: 10.1007/s11657-020-00863-9. Arch Osteoporos. 2021. PMID: 33635381
-
Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations.Cancer Med. 2021 Jul;10(13):4177-4194. doi: 10.1002/cam4.4013. Epub 2021 Jun 8. Cancer Med. 2021. PMID: 34100559 Free PMC article.
-
Dose-Related Effect of Chemotherapy on Bone Mineral Density Among Pediatric Acute Lymphoblastic Leukemia Survivors.J Pediatr Pharmacol Ther. 2024;29(1):53-60. doi: 10.5863/1551-6776-29.1.53. Epub 2024 Feb 7. J Pediatr Pharmacol Ther. 2024. PMID: 38332966 Free PMC article.
-
Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors.PLoS One. 2022 Jul 21;17(7):e0271730. doi: 10.1371/journal.pone.0271730. eCollection 2022. PLoS One. 2022. PMID: 35862357 Free PMC article.
-
A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.Front Endocrinol (Lausanne). 2024 Jan 25;14:1266986. doi: 10.3389/fendo.2023.1266986. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38374961 Free PMC article. Review.
References
-
- Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res. 2002;58(suppl 1):33-38.
-
- Fan C, Georgiou KR, King TJ, Xian CJ. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children. J Biomed Biotechnol. 2011;2011:903097.
-
- Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol. 2000;18:1570-1593.
-
- Grimston SK, Willows ND, Hanley DA. Mechanical loading regime and its relationship to bone mineral density in children. Med Sci Sports Exerc. 1993;25:1203-1210.
-
- Matkovic V. Calcium and peak bone mass. J Intern Med. 1992;231:151-160.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical